These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 28823647

  • 21. The effect of TGF-beta1 and beta-estradiol on glycosaminoglycan and type II collagen distribution in articular chondrocyte cultures.
    Ab-Rahim S, Selvaratnam L, Kamarul T.
    Cell Biol Int; 2008 Jul; 32(7):841-7. PubMed ID: 18479947
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Igf-I extends the chondrogenic potential of human articular chondrocytes in vitro: molecular association between Sox9 and Erk1/2.
    Shakibaei M, Seifarth C, John T, Rahmanzadeh M, Mobasheri A.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1382-95. PubMed ID: 17010943
    [Abstract] [Full Text] [Related]

  • 24. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
    Kim JH, Huh JE, Baek YH, Lee JD, Choi DY, Park DS.
    J Ethnopharmacol; 2011 Mar 24; 134(2):234-42. PubMed ID: 21182922
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Low‑dose halofuginone inhibits the synthesis of type I collagen without influencing type II collagen in the extracellular matrix of chondrocytes.
    Li Z, Fei H, Wang Z, Zhu T.
    Mol Med Rep; 2017 Sep 24; 16(3):3290-3298. PubMed ID: 28713920
    [Abstract] [Full Text] [Related]

  • 28. Salidroside enhances proliferation and maintains phenotype of articular chondrocytes for autologous chondrocyte implantation (ACI) via TGF-β/Smad3 Signal.
    Sun M, Lu Z, Cai P, Zheng L, Zhao J.
    Biomed Pharmacother; 2020 Feb 24; 122():109388. PubMed ID: 31919041
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis.
    Appleton CT, Usmani SE, Bernier SM, Aigner T, Beier F.
    Arthritis Rheum; 2007 Nov 24; 56(11):3693-705. PubMed ID: 17968906
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sprifermin: a recombinant human fibroblast growth factor 18 for the treatment of knee osteoarthritis.
    Li J, Wang X, Ruan G, Zhu Z, Ding C.
    Expert Opin Investig Drugs; 2021 Sep 24; 30(9):923-930. PubMed ID: 34427483
    [Abstract] [Full Text] [Related]

  • 35. Cartilaginous constructs using primary chondrocytes from continuous expansion culture seeded in dense collagen gels.
    Rosenzweig DH, Chicatun F, Nazhat SN, Quinn TM.
    Acta Biomater; 2013 Dec 24; 9(12):9360-9. PubMed ID: 23896567
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9.
    Li Y, Tew SR, Russell AM, Gonzalez KR, Hardingham TE, Hawkins RE.
    Tissue Eng; 2004 Dec 24; 10(3-4):575-84. PubMed ID: 15165474
    [Abstract] [Full Text] [Related]

  • 38. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes.
    Roman-Blas JA, Stokes DG, Jimenez SA.
    Osteoarthritis Cartilage; 2007 Dec 24; 15(12):1367-77. PubMed ID: 17604656
    [Abstract] [Full Text] [Related]

  • 39. Fibroblast growth factor 18 exerts anti-osteoarthritic effects through PI3K-AKT signaling and mitochondrial fusion and fission.
    Yao X, Zhang J, Jing X, Ye Y, Guo J, Sun K, Guo F.
    Pharmacol Res; 2019 Jan 24; 139():314-324. PubMed ID: 30273654
    [Abstract] [Full Text] [Related]

  • 40. Low levels of type II collagen formation (PRO-C2) are associated with response to sprifermin: a pre-defined, exploratory biomarker analysis from the FORWARD study.
    Bay-Jensen AC, Manginelli AA, Karsdal M, Luo Y, He Y, Michaelis M, Guehring H, Ladel C.
    Osteoarthritis Cartilage; 2022 Jan 24; 30(1):92-99. PubMed ID: 34737064
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.